|
Volumn 95, Issue 2, 2002, Pages 243-248
|
Treatment of intracranial metastatic esthesioneuroblastoma
|
Author keywords
Combined modality therapy; Intracranial esthesioneuroblastoma (ENB); Metastatic; Response; Toxicity
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
LOMUSTINE;
VINCRISTINE;
ADULT;
ANEMIA;
ARTICLE;
ASEPTIC MENINGITIS;
BONE MARROW SUPPRESSION;
BRAIN METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CAUSE OF DEATH;
CENTRAL NERVOUS SYSTEM METASTASIS;
CLINICAL ARTICLE;
CLINICAL EXAMINATION;
DRUG RESPONSE;
ERYTHROCYTE TRANSFUSION;
ESTHESIONEUROBLASTOMA;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
LEPTOMENINX;
MALE;
PRIORITY JOURNAL;
RADIATION ENTEROPATHY;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
COMBINED MODALITY THERAPY;
ESTHESIONEUROBLASTOMA, OLFACTORY;
ETHMOID SINUS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NASAL CAVITY;
NOSE NEOPLASMS;
PARANASAL SINUS NEOPLASMS;
RETROSPECTIVE STUDIES;
|
EID: 0037099549
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.10679 Document Type: Article |
Times cited : (35)
|
References (17)
|